Tradewinds Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-350
Closed -$6.06K 727
2024
Q4
$6.06K Hold
350
﹤0.01% 415
2024
Q3
$6.51K Hold
350
﹤0.01% 388
2024
Q2
$5.39K Hold
350
﹤0.01% 377
2024
Q1
$5.17K Hold
350
﹤0.01% 356
2023
Q4
$5K Hold
350
﹤0.01% 287
2023
Q3
$4.88K Hold
350
﹤0.01% 279
2023
Q2
$4.12K Hold
350
﹤0.01% 293
2023
Q1
$4.03K Hold
350
﹤0.01% 296
2022
Q4
$4.35K Hold
350
﹤0.01% 300
2022
Q3
$5K Hold
350
﹤0.01% 269
2022
Q2
$5K Hold
350
﹤0.01% 276
2022
Q1
$5K Hold
350
﹤0.01% 575
2021
Q4
$5K Hold
350
﹤0.01% 590
2021
Q3
$5K Hold
350
﹤0.01% 563
2021
Q2
$6K Hold
350
﹤0.01% 554
2021
Q1
$6K Hold
350
﹤0.01% 527
2020
Q4
$6K Hold
350
﹤0.01% 497
2020
Q3
$5K Hold
350
﹤0.01% 489
2020
Q2
$5K Hold
350
﹤0.01% 480
2020
Q1
$4K Buy
+350
New +$6.45K ﹤0.01% 483

Other funds holding SBRA

Tradewinds Capital Management's SBRA Position: Q1 2025 in Review

Tradewinds Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q1 2025, closing a stake of 350 shares — an estimated $6.06K sold.

Tradewinds Capital Management first reported a position in SBRA in Q1 2020 and held it in 20 quarters. The position peaked at $6.51K in Q3 2024. 403 funds tracked by Wall St. Rank hold SBRA as of Q1 2025.

  • Tradewinds Capital Management reported no remaining Sabra Healthcare REIT position as of Q1 2025 after selling out during the quarter.
  • Tradewinds Capital Management sold 350 Sabra Healthcare REIT shares in Q1 2025, an estimated $6.06K.
  • Tradewinds Capital Management first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 20 quarters.
  • Tradewinds Capital Management's Sabra Healthcare REIT position peaked at $6.51K in Q3 2024.
  • 403 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2025.

Based on Tradewinds Capital Management's 13F filing for Q1 2025, filed 25 Apr 2025.